Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection299

Last updated on 22-8-2019 by Anonymous (not verified)

Public Access


Peer reviewed scientific article


Early diagnosis and management of influenza virus infection directly correlates with the effectiveness in disease control. Current molecular influenza virus tests were designed for use in diagnostic testing facilities, where sophisticated equipment and highly trained technicians are available. A longer turnaround time for the centralized testing than when testing near the sample source could delay the initiation of medical intervention, thereby reducing the efficacy of antiviral treatment. The new assay, the SAMBA (simple amplification-based assay) Flu duplex test, is a dipstick-based molec…

Associated health topics:

QR code

QR code for this page URL